Singapore: As the global investment community continues its recovery from the 2008 financial crisis, the total value of ...
Singapore: As MERS is multiplying incessantly, authorities in Indian state Andhra Pradesh, have issued an advisory to tr...
New Delhi: In a bid to move towards strict enforcement of the new drug pricing policy in India, the country's National P...
Political events in India and the government's lack of conviction on policy matters have taken their toll on India's ima...
Bangalore: The Associated Chambers of Commerce and Industry of India (ASSOCHAM) apprehends that the Supreme Court rulin...
Bangalore: Mylan has signed a definitive agreement with Strides Arcolab to acquire its generic injectable products unit,...
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...
Singapore: Mr Saurabh Gupta, Principal Consultant, Healthcare Advisory Services at PricewaterhouseCoopers India speaks t...
Healthcare, biotech, pharma and life sciences are sectors that involve patient bunch of people who are willing to wait f...
Singapore: US-based BioSpecifics Technologies, a biopharmaceutical company, and its partner Auxilium Pharmaceuticals hav...
Singapore: Glenmark Pharmaceuticals has consolidated $254.45 million for the third quarter ending December 31, 2012, mar...
Singapore: These molecules will have the potential to treat a wide range of immune-mediated diseases in areas such as ga...
Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for...
Bangalore: Dr. Reddy's Laboratories launched Amoxicillin tablets, capsules, and oral suspension, a bioequivalent generi...
Singapore: According to a new report by Research and Markets tilted, 'Niche drug revolution: Has India's generics boom p...
Singapore: In spite of regulatory downfalls and issues, India's leading drug maker, Ranbaxy Laboratories has finally dec...
Singapore: Speaking exclusively to BioSpectrum, Dr Joydeep Goswami, president, APAC and Japan, Life Sciences Solutions, ...
Gone would be the days when patients will have to walk-in to their pathologists for diagnosis of a disease and wait for ...
